Oral semaglutide set to enter phase 3 development for Alzheimer’s disease Digital Health: First smart insulin pens launched in Sweden Diabetes and obesity Rybelsus ® launched in Japan – one of the world’s largest oral anti-diabetes markets 1/2021 • SHARE Magazine 3
Download PDF file